|
|
 |
| |
Pulmonary edema is acute, severe
left ventricular failure with pulmonary venous
hypertension and alveolar flooding. Findings are severe
dyspnea, diaphoresis, wheezing, and sometimes
blood-tinged frothy sputum. Diagnosis is clinical and by
chest x-ray. Treatment is with O2, IV nitrates,
diuretics, and sometimes morphine and short-term IV
positive inotropes, endotracheal intubation, and
mechanical ventilation.
If LV filling pressure increases suddenly, plasma fluid
moves rapidly from pulmonary capillaries into
interstitial spaces and alveoli, causing pulmonary
edema. Although precipitating causes vary by age and
country, about ˝ of cases result from acute coronary
ischemia; some from decompensation of significant
underlying HF, including diastolic dysfunction HF due to
hypertension; and the rest from arrhythmia, an acute
valvular disorder, or acute volume overload often due to
IV fluids. Drug or dietary nonadherence is often
involved.
Symptoms and Signs
Patients present with extreme dyspnea, restlessness, and
anxiety with a sense of suffocation. Cough producing
blood-tinged sputum, pallor, cyanosis, and marked
diaphoresis are common; some patients froth at the
mouth. Frank hemoptysis is uncommon. The pulse is rapid
and low volume, and BP is variable. Marked hypertension
indicates significant cardiac reserve; hypotension with
systolic BP < 100 mg Hg is ominous. Inspiratory fine
crackles are widely dispersed anteriorly and posteriorly
over both lung fields. Marked wheezing (cardiac asthma)
may occur. Noisy respiratory efforts often make cardiac
auscultation difficult; a summation gallop—merger of S3
and S4)—may be present. Signs of RV failure (eg, neck
vein distention, peripheral edema) may be present. |
Diagnosis
A COPD exacerbation can mimic pulmonary edema due to LV failure
or even that due to biventricular failure if cor pulmonale is
present. Pulmonary edema may be the presenting symptom in
patients without a history of cardiac disorders, but COPD
patients with such severe symptoms usually have a history of
COPD, although they may be too dyspneic to relate it.
A chest x-ray, done immediately, is usually diagnostic, showing
marked interstitial edema. Bedside measurement of serum BNP
levels (elevated in pulmonary edema; normal in COPD
exacerbation) is helpful if the diagnosis is in doubt. ECG,
pulse oximetry, and blood tests (cardiac markers, electrolytes,
BUN, creatinine, and, for severely ill patients, ABGs) are done.
An echocardiogram may be helpful to determine the cause of the
pulmonary edema (eg, MI, valvular dysfunction, hypertensive
heart disease, dilated cardiomyopathy) and may influence the
choice of therapies. Hypoxemia can be severe. CO2 retention is a
late, ominous sign of secondary hypoventilation.
Treatment
Initial treatment includes 100% O2 by nonrebreather mask;
upright position; furosemide 0.5 to 1.0 mg/kg IV; nitroglycerin
0.4 mg sublingually q 5 min, followed by an IV drip at 10 to 20
μg/min, titrated upward at 10 μg/min q 5 min as needed to a
maximum 300 μg/min if systolic BP is > 100 mm Hg; and morphine 1
to 5 mg IV once or twice. If hypoxia is significant, noninvasive
ventilatory assistance with bilevel positive airway pressure (BiPAP)
is helpful, but if CO2 retention is present or the patient is
obtunded, tracheal intubation and assisted ventilation are
required.
Specific additional treatment depends on etiology: thrombolysis
or direct percutaneous coronary angioplasty with or without a
stent for acute MI or another acute coronary syndrome; a
vasodilator for severe hypertension; direct-current
cardioversion for supraventricular or ventricular tachycardia;
and an IV β-blocker, IV digoxin, or cautious use of an IV Ca
channel blocker to slow the ventricular rate for rapid atrial
fibrillation (cardioversion is preferred). Other treatments,
such as IV BNP (nesiritide) and new inotropic drugs (levosimendan),
remain under study to elucidate safety profiles and efficacy.
Because fluid status before onset of pulmonary edema is usually
normal in patients with acute MI, diuretics are less useful than
in patients with chronic HF and may precipitate hypotension. If
systolic BP falls < 100 mm Hg or shock develops, IV dobutamine
and an intra-aortic balloon pump (counterpulsation) may be
required.
Once patients are stabilized, long-term HF treatment is as
described above.
Last full review/revision March 2008
by J. Malcolm O. Arnold, MD
|
 |
|